Peter J Gates1, Sophie A Meyerson2, Melissa T Baysari2, Christopher U Lehmann3, Johanna I Westbrook2. 1. Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University, Sydney, Australia; and peter.gates@mq.edu.au. 2. Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University, Sydney, Australia; and. 3. Biomedical Informatics and Pediatrics, Vanderbilt University, Nashville, Tennessee.
Abstract
: media-1vid110.1542/5799876436001PEDS-VA_2018-0805Video Abstract CONTEXT: Patient harm resulting from medication errors drives prevention efforts, yet harm associated with medication errors in children has not been systematically reviewed. OBJECTIVE: To review the incidence and severity of preventable adverse drug events (pADEs) resulting from medication errors in pediatric inpatient settings. DATA SOURCES: Data sources included Cumulative Index of Nursing and Allied Health Literature, Medline, Scopus, the Cochrane Library, and Embase. STUDY SELECTION: Selected studies were published between January 2000 and December 2017, written in the English language, and measured pADEs among pediatric hospital inpatients by chart review or direct observation. DATA EXTRACTION: Data extracted were medication error and harm definitions, pADE incidence and severity rates, items required for quality assessment, and sample details. RESULTS: Twenty-two studies were included. For children in general pediatric wards, incidence was at 0 to 17 pADEs per 1000 patient days or 1.3% of medication errors (of any type) compared with 0 to 29 pADEs per 1000 patient days or 1.5% of medication errors in ICUs. Hospital-wide studies contained reports of up to 74 pADEs per 1000 patient days or 2.6% of medication errors. The severity of pADEs was mainly minor. LIMITATIONS: Limited literature on the severity of pADEs is available. Additional study will better illuminate differences among hospital wards and among those with or without health information technology. CONCLUSIONS: Medication errors in pediatric settings seldom result in patient harm, and if they do, harm is predominantly of minor severity. Implementing health information technologies was associated with reduced incidence of harm.
: media-1vid110.1542/5799876436001PEDS-VA_2018-0805Video Abstract CONTEXT: Patient harm resulting from medication errors drives prevention efforts, yet harm associated with medication errors in children has not been systematically reviewed. OBJECTIVE: To review the incidence and severity of preventable adverse drug events (pADEs) resulting from medication errors in pediatric inpatient settings. DATA SOURCES: Data sources included Cumulative Index of Nursing and Allied Health Literature, Medline, Scopus, the Cochrane Library, and Embase. STUDY SELECTION: Selected studies were published between January 2000 and December 2017, written in the English language, and measured pADEs among pediatric hospital inpatients by chart review or direct observation. DATA EXTRACTION: Data extracted were medication error and harm definitions, pADE incidence and severity rates, items required for quality assessment, and sample details. RESULTS: Twenty-two studies were included. For children in general pediatric wards, incidence was at 0 to 17 pADEs per 1000 patient days or 1.3% of medication errors (of any type) compared with 0 to 29 pADEs per 1000 patient days or 1.5% of medication errors in ICUs. Hospital-wide studies contained reports of up to 74 pADEs per 1000 patient days or 2.6% of medication errors. The severity of pADEs was mainly minor. LIMITATIONS: Limited literature on the severity of pADEs is available. Additional study will better illuminate differences among hospital wards and among those with or without health information technology. CONCLUSIONS: Medication errors in pediatric settings seldom result in patient harm, and if they do, harm is predominantly of minor severity. Implementing health information technologies was associated with reduced incidence of harm.
Authors: Peter J Gates; Melissa T Baysari; Madlen Gazarian; Magdalena Z Raban; Sophie Meyerson; Johanna I Westbrook Journal: Drug Saf Date: 2019-11 Impact factor: 5.606
Authors: James W Antoon; Matt Hall; Alison Herndon; Alison Carroll; My-Linh Ngo; Katherine L Freundlich; Justine C Stassun; Patricia Frost; David P Johnson; Swati B Chokshi; Charlotte M Brown; Whitney L Browning; James A Feinstein; Carlos G Grijalva; Derek J Williams Journal: Pediatrics Date: 2020-10-09 Impact factor: 7.124
Authors: Daniel J France; Jason Slagle; Emma Schremp; Sarah Moroz; L Dupree Hatch; Peter Grubb; Timothy J Vogus; Matthew S Shotwell; Amanda Lorinc; Christoph U Lehmann; Jamie Robinson; Marlee Crankshaw; Maria Sullivan; Timothy A Newman; Tamara Wallace; Matthew B Weinger; Martin L Blakely Journal: J Patient Saf Date: 2021-12-01 Impact factor: 2.844
Authors: Alain K Koyama; Claire-Sophie Sheridan Maddox; Ling Li; Tracey Bucknall; Johanna I Westbrook Journal: BMJ Qual Saf Date: 2019-08-07 Impact factor: 7.035
Authors: Peter J Gates; Melissa T Baysari; Virginia Mumford; Magdalena Z Raban; Johanna I Westbrook Journal: Drug Saf Date: 2019-08 Impact factor: 5.606
Authors: Peter J Gates; Rae-Anne Hardie; Magdalena Z Raban; Ling Li; Johanna I Westbrook Journal: J Am Med Inform Assoc Date: 2021-01-15 Impact factor: 4.497
Authors: Lindemberg Assunção-Costa; Charleston Ribeiro Pinto; Juliana Ferreira Fernandes Machado; Cleidenete Gomes Valli; Luís Eugênio Portela Fernandes de Souza; Bryony Dean Franklin Journal: J Public Health Res Date: 2022-03-14
Authors: Edmundo Vázquez-Cornejo; Olga Morales-Ríos; Gabriela Hernández-Pliego; Carlo Cicero-Oneto; Juan Garduño-Espinosa Journal: PLoS One Date: 2022-03-24 Impact factor: 3.240